SIMPAC decides 35.4 bn KRW PEF investment, revises acquisition date
-
SIMPAC decided to invest 35.4 billion KRW as a limited partner in GenoValueUp PEF, acquiring a 46.89% stake (total commitment 75.5 billion KRW)
-
Acquisition date revised from 2026-04-29 to 2026-05-08
-
SIMPAC holds a call option on the SPC's shares under the PEF
-
The investee is newly established, no financial data available
-
Investment represents 5.28% of equity of 670.3 billion KRW (2025 consolidated)
KOSPI Filing Information
-
Filing: [Correction of Description] Decision on Acquisition of Stocks and Equity Securities of Other Corporations
-
Company: SIMPAC (009160)
-
Submission: SIMPAC Inc.
-
Receipt: 04-29-2026
-
Under KRX KOSPI Market Division